MGC Pharmaceuticals' "numbers were very good" in Q4 2022
News release
by
MGC Pharmaceuticals Ltd
London, UK
|
February 08, 2023 08:47 AM Eastern Standard Time
MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Proactive's Thomas Warner about how the business performed during the fourth quarter of 2022. Clements says that the "numbers were very good" and reveals more details about how the business is changing as it heads into a new calendar year.
Contact Details
Proactive UK Ltd
+44 20 7989 0813
